Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Linn

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
BMC Cancer|July 26, 2018
Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannotKarin Beelen, Mark Opdam, Tesa Severson, et al.
Critical Reviews in Oncology/Hematology|October 29, 2021
Receptor status of breast cancer diagnosed during pregnancy: A literature reviewCarsten F J Bakhuis, Britt B M Suelmann, Carmen van Dooijeweert, et al.
BMC Cancer|August 15, 2015
Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13Cristiane Bentin Toaldo, Xanthippi Alexi, Karin Beelen, et al.
Lancet (London, England)|June 18, 2013
Tamoxifen therapy for patients with breast cancerPatrick Neven, Heikki Joensuu, Heikki Joenssu, et al.
Breast Cancer Research : BCR|January 30, 2026
One size does not fit all: data-driven insights of patient-reported outcomes to tailor supportive care in breast cancerEva Boomstra, Kelly M de Ligt, Renaud Tissier, et al.
Breast Cancer Research and Treatment|March 23, 2016
Equivalence of MammaPrint array types in clinical trials and diagnosticsInès Beumer, Anke Witteveen, Leonie Delahaye, et al.
Biomarker Insights|December 17, 2016
Prognostic Value of MammaPrint<sup>®</sup> in Invasive Lobular Breast CancerInès J Beumer, Marion Persoon, Anke Witteveen, et al.
The American Journal of Pathology|September 26, 2003
Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histologyTorsten O Nielsen, Forrest D Hsu, John X O'Connell, et al.
Breast Cancer Research and Treatment|September 6, 2011
Impact of mammographic screening on the detection of good and poor prognosis breast cancersLaura J Esserman, Yiwey Shieh, Emiel J T Rutgers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 15, 2020
Radiotherapy after primary CHEMotherapy (RAPCHEM): Practice variation in a Dutch registration study (BOOG 2010-03)Liesbeth J Boersma, Janneke Verloop, Adri C Voogd, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
BMC Cancer|July 26, 2018
Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannotKarin Beelen, Mark Opdam, Tesa Severson, et al.
Critical Reviews in Oncology/Hematology|October 29, 2021
Receptor status of breast cancer diagnosed during pregnancy: A literature reviewCarsten F J Bakhuis, Britt B M Suelmann, Carmen van Dooijeweert, et al.
BMC Cancer|August 15, 2015
Protein Kinase A-induced tamoxifen resistance is mediated by anchoring protein AKAP13Cristiane Bentin Toaldo, Xanthippi Alexi, Karin Beelen, et al.
Lancet (London, England)|June 18, 2013
Tamoxifen therapy for patients with breast cancerPatrick Neven, Heikki Joensuu, Heikki Joenssu, et al.
Breast Cancer Research : BCR|January 30, 2026
One size does not fit all: data-driven insights of patient-reported outcomes to tailor supportive care in breast cancerEva Boomstra, Kelly M de Ligt, Renaud Tissier, et al.
Breast Cancer Research and Treatment|March 23, 2016
Equivalence of MammaPrint array types in clinical trials and diagnosticsInès Beumer, Anke Witteveen, Leonie Delahaye, et al.
Biomarker Insights|December 17, 2016
Prognostic Value of MammaPrint<sup>®</sup> in Invasive Lobular Breast CancerInès J Beumer, Marion Persoon, Anke Witteveen, et al.
The American Journal of Pathology|September 26, 2003
Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histologyTorsten O Nielsen, Forrest D Hsu, John X O'Connell, et al.
Breast Cancer Research and Treatment|September 6, 2011
Impact of mammographic screening on the detection of good and poor prognosis breast cancersLaura J Esserman, Yiwey Shieh, Emiel J T Rutgers, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 15, 2020
Radiotherapy after primary CHEMotherapy (RAPCHEM): Practice variation in a Dutch registration study (BOOG 2010-03)Liesbeth J Boersma, Janneke Verloop, Adri C Voogd, et al.
Pageof 5